Corundum Trust Company’s CVS Health CVS Stock Holding History

Corundum Trust Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-382	Closed	-$28.8K	–	68
2025 Q3	$28.8K	Buy	+382	New	+$26.2K	0.06%	91

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corundum Trust Company's CVS Position: Q4 2025 in Review

Corundum Trust Company sold out of CVS Health (CVS) in Q4 2025, closing a stake of 382 shares — an estimated $28.8K sold.

Corundum Trust Company first reported a position in CVS in Q3 2025 and held it in 1 quarter. The position peaked at $28.8K in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

Corundum Trust Company reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 382 CVS Health shares in Q4 2025, an estimated $28.8K.
Corundum Trust Company first reported a position in CVS Health in Q3 2025 and held it in 1 quarter.
Corundum Trust Company's CVS Health position peaked at $28.8K in Q3 2025.
1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.